Illumina completes Grail acquisition

Illumina completes the divestiture of GRAIL

SAN DIEGO, June 24, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced the successful completion of the spin-off of GRAIL. This ...

Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving ...

(NASDAQ: ILMN) announced today that it has acquired GRAIL, a healthcare company focused on life-saving early detection of multiple cancers, but ...

Rocky history of Illumina's Grail deal | Reuters

Illumina closed the acquisition of Grail in 2021, before European regulators could complete their antitrust review, resulting in a hefty ...

Illumina to Acquire GRAIL to Launch New Era of Cancer Detection

--(BUSINESS WIRE)-- Illumina, Inc. (NASDAQ: ILMN) and GRAIL, a healthcare company whose mission is focused on multi-cancer early detection, ...

Illumina completes Grail acquisition, regulators be damned

Despite looming antitrust investigations on both sides of the Atlantic, Illumina has pushed forward with finalizing its $8 billion deal to ...

Illumina completes Grail spinoff - MedTech Dive

Dive Brief: Illumina completed its spinoff of Grail, a maker of cancer blood tests, ending the company's attempted acquisition nearly four ...

Statement Regarding Illumina's Decision to Divest Grail

Illumina's decision to unwind its acquisition of Grail ensures the market for cancer detection tests remains competitive and delivers a choice of high-quality ...

Illumina parts ways with Grail, with divestiture complete

Illumina completes Grail acquisition, regulators be damned. Fast forward to today, when, as of this writing and before official trading, Grail's ...

Illumina's European Court Victory Can't Salvage Grail Acquisition ...

The commission levied it because Illumina closed the Grail acquisition before the regulator could complete its review. But the Court of ...

Grail to Begin Trading on Nasdaq as Illumina Completes Divestiture

... acquisition. However, without waiting for the review to be completed, Illumina and Grail pushed through with their merger, forcing the EC to ...

Illumina Completes Grail Divestment - GenomeWeb

Illumina said Monday after the close of the market that it has successfully spun off liquid biopsy firm Grail.

Illumina completes $8B Grail acquisition, companies remain ...

Illumina (NSDQ:ILMN) announced that it completed its long-awaited and much-scrutinized acquisition of cancer detection company Grail.

FTC orders Illumina to divest Grail acquisition - CNBC

The Federal Trade Commission on Monday ordered Illumina to divest its controversial acquisition of cancer test developer Grail, saying the deal would stifle ...

Illumina Remains Committed to GRAIL Acquisition to Accelerate ...

Illumina Remains Committed to GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test. SAN DIEGO--(BUSINESS WIRE)-- ...

Illumina to divest cancer test maker Grail after antitrust battles | Reuters

Europe had proposed measures for Illumina to unwind its acquisition of Grail. ... See here for a complete list of exchanges and delays.

Illumina Committed to Pursuing GRAIL Acquisition to Accelerate ...

Illumina intends to pursue all legal options in order to complete the acquisition and deliver the strategic benefits to its stakeholders. For clinical ...

Illumina completes the divestiture of GRAIL - PR Newswire

PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced the successful completion of the spin-off of GRAIL. This milestone follows the ...

Illumina Announces Decision to Divest GRAIL

GRAIL Acquisition · Governance · Resources · Investor FAQs · Investor Kit ... You must click the activation link in order to complete your ...

StockWatch: "Final Resolution" Set for Illumina's Grail Saga

Illumina had justified the Grail acquisition by asserting that it ... complete responses, two very good partial responses, four partial ...

Roundup: Illumina's long goodbye to cancer test maker Grail

Illumina took a bold step in 2021 when it closed the $8 billion acquisition of Grail, maker of a multi-cancer early detection test, before securing the ...